Human medicines European public assessment report (EPAR): Rolcya, denosumab, Date of authorisation: 17/07/2025, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 27 November 2025 - 15:35

Human medicines European public assessment report (EPAR): Rolcya, denosumab, Date of authorisation: 17/07/2025, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/rolcya

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters